Literature DB >> 23716556

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

Livio Pagano1, Oliver A Cornely, Alessandro Busca, Morena Caira, Simone Cesaro, Cristiana Gasbarrino, Corrado Girmenia, Werner J Heinz, Raoul Herbrecht, Cornelia Lass-Flörl, Annamaria Nosari, Leonardo Potenza, Zdenek Racil, Volker Rickerts, Donald C Sheppard, Arne Simon, Andrew J Ullmann, Caterina Giovanna Valentini, Jörg Janne Vehreschild, Anna Candoni, Maria J G T Vehreschild.   

Abstract

Entities:  

Keywords:  combination therapy; hematologic malignancies; invasive fungal infections; lipid formulations of amphotericin B; mucormycosis; posaconazole

Mesh：

Substances：

Year:  2013        PMID： 23716556      PMCID： PMC3789474          DOI： 10.3324/haematol.2012.083063

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.

Authors:  F Sabatelli; R Patel; P A Mann; C A Mendrick; C C Norris; R Hare; D Loebenberg; T A Black; P M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.

Authors:  Nikolaos G Almyroudis; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Shimon Kusne
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

3.  In vitro activities of combinations of amphotericin B, posaconazole and four other agents against Rhizopus.

Authors:  Frederic Ballester; F Javier Pastor; Josep Guarro
Journal:  J Antimicrob Chemother       Date:  2008-01-28       Impact factor: 5.790

4.  Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients.

Authors:  Hsin-Yun Sun; Graeme Forrest; Krishan L Gupta; Jose M Aguado; Olivier Lortholary; Marino Blanes Julia; Nasia Safdar; Robin Patel; Shimon Kusne; Nina Singh
Journal:  Transplantation       Date:  2010-07-15       Impact factor: 4.939

5.  Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

Authors:  A Skiada; L Pagano; A Groll; S Zimmerli; B Dupont; K Lagrou; C Lass-Florl; E Bouza; N Klimko; P Gaustad; M Richardson; P Hamal; M Akova; J F Meis; J-L Rodriguez-Tudela; E Roilides; A Mitrousia-Ziouva; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

6.  Forty-one recent cases of invasive zygomycosis from a global clinical registry.

Authors:  M J G T Rüping; W J Heinz; A J Kindo; V Rickerts; C Lass-Flörl; C Beisel; R Herbrecht; Y Roth; G Silling; A J Ullmann; K Borchert; G Egerer; J Maertens; G Maschmeyer; A Simon; M Wattad; G Fischer; J J Vehreschild; O A Cornely
Journal:  J Antimicrob Chemother       Date:  2009-12-11       Impact factor: 5.790

7.  Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Authors:  Susanne Perkhofer; Maria Locher; Manuel Cuenca-Estrella; Reinhard Rüchel; Reinhard Würzner; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

8.  The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebremariam; Samuel W French; John E Edwards; Brad Spellberg
Journal:  J Antimicrob Chemother       Date:  2009-11-26       Impact factor: 5.790

9.  Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

Authors:  Jo-Anne H van Burik; Roberta S Hare; Howard F Solomon; Michael L Corrado; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-02-21       Impact factor: 9.079

10.  Posaconazole mono- or combination therapy for treatment of murine zygomycosis.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebremariam; Julie A Schwartz; John E Edwards; Brad Spellberg
Journal:  Antimicrob Agents Chemother       Date:  2008-10-20       Impact factor: 5.191
View more
  28 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

2.  Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy.

Authors:  Jeffrey D Jenks; Sharon L Reed; Danila Seidel; Philipp Koehler; Oliver A Cornely; Sanjay R Mehta; Martin Hoenigl
Journal:  Int J Antimicrob Agents       Date:  2018-08-09       Impact factor: 5.283

Review 3.  Diagnosis and Treatment of Acute Invasive Fungal Sinusitis in Cancer and Transplant Patients.

Authors:  Monica Fung; Jennifer Babik; Ian M Humphreys; Greg E Davis
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

Review 4.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

5.  A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia.

Authors:  Jiaojiao Zhang; Jing Luo; Xiangqin Weng; Yongmei Zhu; Gaurav Goyal; Fabiana Perna; Manuel Espinoza-Gutarra; Lu Jiang; Li Chen; Jian-Qing Mi
Journal:  Ann Transl Med       Date:  2022-06

6.  Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review.

Authors:  Paola Di Carlo; Roberto Pirrello; Giuliana Guadagnino; Pierina Richiusa; Antonio Lo Casto; Caterina Sarno; Francesco Moschella; Daniela Cabibi
Journal:  Case Rep Med       Date:  2014-05-27

Review 7.  Biology, systematics, and clinical manifestations of Zygomycota infections.

Authors:  A Muszewska; J Pawłowska; P Krzyściak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-11       Impact factor: 3.267

8.  Ventriculitis due to infection with Rhizopus arrhizus.

Authors:  Stefan Hagel; Christian Ewald; Torsten Doenst; Svea Sachse; Jürgen Roedel; Mathias W Pletz
Journal:  Med Mycol Case Rep       Date:  2015-12-15

9.  Mucorales-Specific T Cells in Patients with Hematologic Malignancies.

Authors:  Leonardo Potenza; Daniela Vallerini; Patrizia Barozzi; Giovanni Riva; Andrea Gilioli; Fabio Forghieri; Anna Candoni; Simone Cesaro; Chiara Quadrelli; Johan Maertens; Giulio Rossi; Monica Morselli; Mauro Codeluppi; Cristina Mussini; Elisabetta Colaci; Andrea Messerotti; Ambra Paolini; Monica Maccaferri; Valeria Fantuzzi; Cinzia Del Giovane; Alessandro Stefani; Uliano Morandi; Rossana Maffei; Roberto Marasca; Franco Narni; Renato Fanin; Patrizia Comoli; Luigina Romani; Anne Beauvais; Pier Luigi Viale; Jean Paul Latgè; Russell E Lewis; Mario Luppi
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.